ClinConnect ClinConnect Logo
Search / Trial NCT06669962

Characterisation of the Biochemical Profile and Physiology of the Coronary Circulation in Takotsubo Syndrome

Launched by A.O.U. CITTÀ DELLA SALUTE E DELLA SCIENZA · Oct 31, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a condition called Takotsubo syndrome, which affects the heart and can cause symptoms similar to a heart attack. The main goal of the study is to understand how well the small blood vessels in the heart are working in patients with this condition and how this relates to their symptoms and overall health. Researchers will look at various factors, including the risk of serious complications and how patients feel during their hospital stay and afterward.

To participate in the trial, you must be at least 18 years old and diagnosed with Takotsubo syndrome. If you choose to join, you'll be asked to sign a consent form, and you can expect to be monitored during your hospital stay and followed up on for up to a year. This study aims to help doctors learn more about this condition to improve treatment and patient care in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years;
  • Diagnosis of Takotsubo syndrome
  • Signing of informed consent
  • Exclusion Criteria:
  • Age \<18 years;
  • Refusal to sign written informed consent.

About A.O.U. Città Della Salute E Della Scienza

A.O.U. Città della Salute e della Scienza is a leading healthcare institution based in Turin, Italy, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic hospital, it integrates cutting-edge research with clinical practice, fostering collaboration among multidisciplinary teams to address complex health challenges. The institution is committed to enhancing therapeutic options and outcomes for patients by conducting rigorous and ethically sound clinical studies that adhere to the highest standards of scientific integrity.

Locations

Turin, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported